Sepsis: From Syndrome to Personalized Care
This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.
| Condition(s) | Sepsis Syndrome, Sepsis, Sepsis, Severe, Septic Shock |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled. |
| Who can participate | Inclusion Criteria: * admitted to emergency department OUH, Ullevål. * managed by the medical rapid response team or the sepsis rapid response team Exclusion Criteria: * Not given informed consent by patient or next of kin (if patient is not able to) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Oslo University Hospital |
| Locations | Oslo, Norway |
| Start date | 2020-01-06 |
| NCT ID | NCT04203979 |
| Official listing | https://clinicaltrials.gov/study/NCT04203979 |